Lalji K Gediya Selected Research

3beta- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- diene

8/2008

Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lalji K Gediya Research Topics

Disease

12	Neoplasms (Cancer) 01/2018 - 12/2004
12	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 12/2004
4	Breast Neoplasms (Breast Cancer) 07/2014 - 12/2004
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Triple Negative Breast Neoplasms 03/2019
1	Carcinogenesis 01/2013
1	Carcinoma (Carcinomatosis) 05/2012

Drug/Important Bio-Agent (IBA)

6	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 05/2007
4	4-(1H-imidazol-1-yl)retinoic acidIBA 07/2014 - 12/2004
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2012 - 12/2004
3	Pharmaceutical PreparationsIBA 06/2013 - 07/2008
3	Histone Deacetylase InhibitorsIBA 01/2013 - 03/2008
3	Biological ProductsIBA 11/2011 - 12/2004
2	ChemokinesIBA 03/2019 - 01/2013
2	Eukaryotic Initiation Factor-4EIBA 03/2019 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 03/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2008
2	3- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA 10/2017 - 06/2013
2	Estrogen ReceptorsIBA 01/2013 - 05/2012
2	Vorinostat FDA Link 01/2013 - 07/2005
2	AndrogensIBA 11/2011 - 04/2005
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 08/2008 - 04/2005
2	Androgen Antagonists (Antiandrogens)IBA 08/2008 - 04/2005
2	Hormones (Hormone)IBA 07/2008 - 04/2008
2	RetinoidsIBA 03/2008 - 07/2005
1	CytokinesIBA 03/2019
1	4- (+;- )- (1H- imidazole- 1- yl)- N- (4- fluorophenyl)- (E)- retinamideIBA 03/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	retinamideIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	VimentinIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	CateninsIBA 01/2018
1	ClaudinsIBA 01/2018
1	LigandsIBA 10/2017
1	ThapsigarginIBA 07/2014
1	Aromatase InhibitorsIBA 07/2014
1	Aromatase (CYP19)IBA 07/2014
1	Letrozole (Femara)FDA LinkGeneric 07/2014
1	bardoxolone methylIBA 01/2013
1	Macrophage Colony-Stimulating FactorIBA 01/2013
1	TriterpenesIBA 01/2013
1	Drug CombinationsIBA 01/2013
1	A 7 (A-7)IBA 01/2013
1	bardoxoloneIBA 01/2013
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 05/2012
1	Estrogens (Estrogen)FDA Link 05/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2012
1	Abiraterone AcetateIBA 11/2011
1	abirateroneIBA 11/2011
1	CamptothecinIBA 11/2009
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2009
1	3beta- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA 08/2008
1	Mixed Function Oxygenases (Monooxygenases)IBA 08/2008
1	bicalutamide (Casodex)FDA LinkGeneric 08/2008
1	ProdrugsIBA 07/2008
1	tacedinaline (CI 994)IBA 03/2008
1	Isotretinoin (Accutane)FDA LinkGeneric 03/2008
1	entinostat (MS 275)IBA 03/2008
1	theasinensin AIBA 03/2008
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2005
1	E 10 (E-10)IBA 04/2005
1	Carboxylic AcidsIBA 12/2004
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2004
1	Growth InhibitorsIBA 12/2004

Therapy/Procedure

4	Therapeutics 03/2019 - 11/2009
3	Castration 01/2018 - 04/2005
1	Chemoprevention 01/2013